Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines.
Ratings
2 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. Paulus Stoffels$1.8B
Market Cap • 25/07/20241999
(há 25 anos)
2015
(9 years ago)
NASDAQ
Listagem
Mechelen
1.338
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
GLPGSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.